Log in

2370 MEDINET Co., Ltd. TSE · Japan

MEDINET Co. (2370) news

MEDINET Co., Ltd. is a public biotech or pharmaceutical company listed on TSE under the ticker 2370, recorded under Japan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest MEDINET Co. news

We have not published a story on MEDINET Co. yet. When there is news, it will appear here.

Questions about MEDINET Co.

What is the ticker symbol of MEDINET Co.?

MEDINET Co., Ltd. trades under the ticker 2370 on TSE.

Where is MEDINET Co. listed?

MEDINET Co., Ltd. is listed on TSE.

Which country or territory is MEDINET Co. listed under?

Our directory records MEDINET Co., Ltd. under Japan.

What does MEDINET Co. do?

Our directory classifies MEDINET Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of MEDINET Co.?

The ISIN recorded for MEDINET Co., Ltd. is JP3920990003.

Does aibio.space cover MEDINET Co.?

aibio.space lists MEDINET Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to MEDINET Co.?

Companies in our directory listed in the same country and business area as MEDINET Co.: Human Metabolome Technologies, StemCell Institute, Oncolys BioPharma, Kidswell Bio, Kringle Pharma, PRISM BioLab Co. LTD.

Investor discussion: MEDINET Co.

Members talk about MEDINET Co. (2370). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSE:2370 on TradingView.

Listing details

MEDINET Co., Ltd. is a public biotech or pharmaceutical company listed on TSE under the ticker 2370, recorded under Japan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
MEDINET Co., Ltd.
Ticker
2370
Listing
TSE
Country or territory
Japan
Business scope
Biotechnology
ISIN
JP3920990003
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.